Revance Therapeutics | 净收入

Net Income 更改 日
ALKERMES USD 47.76M 189.31M 2023-09
Eli Lilly USD 2.19B 2.25B 2023-12
Neurocrine Biosciences USD 83.1M 12.4M 2023-09
Pacira USD 24.87M 14.01M 2023-12
Supernus Pharmaceuticals USD 1.18M 17.15M 2023-12



Revance Therapeutics 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.